PAVmed Inc. — Director's Dealing 2018

Jul 11, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2018-06-12

Reporting Person: Aklog Lishan (Director, Chairman and CEO, 10% Owner)
Reporting Person: Pavilion Venture Partners LLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-12	Common Stock	X	1018	—	Acquired	2303	Indirect
2018-06-12	Common Stock	X	980	—	Acquired	2280	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-04-20	Series Z Warrants	$1.60	G	12450	Disposed	2024-04-30	Common Stock (12450)	Direct
2018-06-12	Subscription Rights (Right to Buy)	$1.15	X	1018	Disposed	2018-06-12	Units (1 share of Common Stock and 1 Series Z Warrant) (1018)	Indirect
2018-06-12	Series Z Warrants	$1.60	X	1018	Acquired	2024-04-30	Common Stock (1018)	Indirect
2018-06-12	Subscription Rights (Right to Buy)	$1.15	X	980	Disposed	2018-06-12	Units (1 share of Common Stock and 1 Series Z Warrant) (980)	Indirect
2018-06-12	Series Z Warrants	$1.60	X	980	Acquired	2024-04-30	Common Stock (980)	Indirect
2018-06-26	Series Z Warrants	$1.60	J	968019	Acquired	2024-04-30	Common Stock (2078285)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	588413	Direct
Common Stock	4456570	Indirect
Common Stock	20000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series Z Warrants	$1.60	2024-04-30	Common Stock (10000)	10000	Indirect

Footnotes

F1: The reporting person purchased units from the issuer in the issuer's equity rights offering, each unit consisting of one share of the issuer's common stock and one Series Z Warrant, at a price of $1.15 per unit.

F2: Dr. Aklog is a member and sole manager of Pavilion Venture Partners LLC, and has sole voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein.

F3: Dr. Aklog is a co-manager of HCFP/AG LLC, and shares joint voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his pecuniary interest therein.

F4: Reflects 350,538 Series Z Warrants that previously were held indirectly by Dr. Aklog through HCFP/Capital Partners III LLC, and became held directly by Dr. Aklog on June 26, 2018.

F5: The Series Z Warrants were contributed to such entity by its members for no consideration. The contributed Series Z Warrants include 322,673 Series Z Warrants that were previously held indirectly by Dr. Aklog through HCFP/Capital Partners III LLC and became held directly by Dr. Aklog on June 26, 2016.